Optinose CEO Ramy Mahmoud stated: “More than 80% of patients with chronic sinusitis report frustration with symptom relief when using a standard-delivery nasal steroid sprays, and patients ...
As the category leader (22% market share Q2 2018), Otrivin' s objective was to drive usage of nasal sprays and subsequently Otrivin Further, timing was... We’re long-term subscribers to WARC and it’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback